LEV102 Topical Gel in Acquired Blepharoptosis
Public ClinicalTrials.gov record NCT05715346. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2a Study of LEV102 Topical Gel in Subjects With Acquired Blepharoptosis
Study identification
- NCT ID
- NCT05715346
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Levation Pharma, Ltd.
- Industry
- Enrollment
- 33 participants
Conditions and interventions
Conditions
Interventions
- LEV102 1.0% Drug
- LEV102 2.0% Drug
- Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 25 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 22, 2023
- Primary completion
- Jun 23, 2023
- Completion
- Jun 23, 2023
- Last update posted
- Nov 12, 2024
2023
United States locations
- U.S. sites
- 3
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Eye Research Foundation | Newport Beach | California | 92663 | — |
| Steve Yoelin Medical Associates | Newport Beach | California | 92663 | — |
| Brian Biesman, M.D | Nashville | Tennessee | 37203 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05715346, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 12, 2024 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05715346 live on ClinicalTrials.gov.